| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Atherosclerosis--an inflammatory disease.
|
N Engl J Med
|
1999
|
59.28
|
|
2
|
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.
|
Lancet
|
2013
|
7.03
|
|
3
|
Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.
|
Annu Rev Immunol
|
2007
|
5.83
|
|
4
|
Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.
|
JAMA
|
2001
|
4.31
|
|
5
|
Pro-resolving lipid mediators are leads for resolution physiology.
|
Nature
|
2014
|
4.15
|
|
6
|
Infection regulates pro-resolving mediators that lower antibiotic requirements.
|
Nature
|
2012
|
4.04
|
|
7
|
Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions.
|
J Exp Med
|
2008
|
3.35
|
|
8
|
Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease.
|
Circulation
|
1998
|
2.83
|
|
9
|
National trends in lower extremity bypass surgery, endovascular interventions, and major amputations.
|
J Vasc Surg
|
2009
|
2.55
|
|
10
|
C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study.
|
Circulation
|
2005
|
2.53
|
|
11
|
Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.
|
J Nucl Med
|
2008
|
2.52
|
|
12
|
Trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft.
|
J Vasc Surg
|
2011
|
2.42
|
|
13
|
Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis.
|
Proc Natl Acad Sci U S A
|
2006
|
2.31
|
|
14
|
Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery.
|
J Vasc Surg
|
2006
|
2.14
|
|
15
|
Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study.
|
Ann Intern Med
|
2008
|
2.01
|
|
16
|
Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation.
|
J Clin Invest
|
2011
|
1.92
|
|
17
|
Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis.
|
JACC Cardiovasc Interv
|
2011
|
1.85
|
|
18
|
Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis.
|
Radiology
|
2002
|
1.65
|
|
19
|
Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis.
|
Am J Pathol
|
2010
|
1.47
|
|
20
|
Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
1.39
|
|
21
|
Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death).
|
Am J Cardiol
|
2005
|
1.27
|
|
22
|
Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden.
|
J Vasc Surg
|
2003
|
1.25
|
|
23
|
Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women: a prospective study.
|
Circulation
|
2009
|
1.08
|
|
24
|
1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients.
|
J Alzheimers Dis
|
2013
|
1.05
|
|
25
|
Biomarkers in peripheral arterial disease patients and near- and longer-term mortality.
|
J Vasc Surg
|
2010
|
1.00
|
|
26
|
Biomarkers of inflammation and malnutrition associated with early death in healthy elderly people.
|
J Am Geriatr Soc
|
2008
|
0.99
|
|
27
|
Inflammation, Atherosclerosis, and Coronary Artery Disease: PET/CT for the Evaluation of Atherosclerosis and Inflammation.
|
Clin Med Insights Cardiol
|
2015
|
0.90
|
|
28
|
Matrix metalloproteinases and peripheral arterial disease.
|
Intern Emerg Med
|
2009
|
0.89
|
|
29
|
In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation.
|
J Vasc Surg
|
2009
|
0.89
|
|
30
|
The vascular adventitia: its role in the arterial injury response.
|
Vasc Endovascular Surg
|
2011
|
0.89
|
|
31
|
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages.
|
FASEB J
|
2014
|
0.86
|
|
32
|
Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
|
Am Heart J
|
2003
|
0.86
|
|
33
|
Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease.
|
J Vasc Surg
|
2013
|
0.84
|
|
34
|
Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.
|
J Am Heart Assoc
|
2014
|
0.83
|
|
35
|
Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study.
|
J Lipid Res
|
2015
|
0.82
|
|
36
|
Thresholds for Arterial Wall Inflammation Quantified by (18)F-FDG PET Imaging: Implications for Vascular Interventional Studies.
|
JACC Cardiovasc Imaging
|
2016
|
0.78
|